-

10:21:15 PM

LIVE Real Time LHDX Stock Market News

LHDX - LHDX

05/06/21 4:05 PM

Nasdaq : LHDX

Lucira Health to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will

RHEA-AI

neutral

04/29/21 4:00 PM

Nasdaq : LHDX

Lucira Health to Announce First Quarter 2021 Financial Results

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company

RHEA-AI

neutral

04/29/21 6:00 AM

Nasdaq : LHDX

Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT(TM) COVID-19 Self-Test

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the opening of a new production center in the Dominican Republic by its manufacturing partner Jabil Inc.

RHEA-AI

neutral

04/26/21 9:35 AM

Nasdaq : LHDX

Health Canada Authorizes First COVID-19 Test For Self-Testing At Home

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that Health Canada issued an Authorization with Conditions for the LUCIRA(TM) CHECK IT COVID-19 test kit. The

RHEA-AI

neutral

04/22/21 3:49 PM

Nasdaq : LHDX

For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debuts in San Francisco Bay Area this Friday with LUCIRA(TM) Check It COVID-19 At-Home Test

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that for the first time ever, NBA fans can test themselves for COVID-19 before attending a live game. This

RHEA-AI

neutral

04/22/21 9:20 AM

Nasdaq : LHDX

For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debuts in San Francisco Bay Area this Friday with LUCIRA(TM) Check It COVID-19 At-Home Test

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that for the first time ever, NBA fans can test themselves for COVID-19 before attending a live game. This

RHEA-AI

neutral

04/12/21 7:00 AM

Nasdaq : LHDX

FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT(TM) COVID-19 At-Home Test. Available Now.

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the

RHEA-AI

neutral

04/09/21 6:00 AM

Nasdaq : LHDX

LUCIRA COVID-19 Test Kit Identifies Viral Variants

Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today confirmed it can successfully identify the "double mutant" variant of COVID-19 with its Lucira molecular test

RHEA-AI

neutral

02/11/21 6:00 AM

Nasdaq : LHDX

U.S. Physicians Can Now Order Lucira Health Self-Administered, Lab Quality, COVID-19 Molecular Test for Home or Office

Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online from lucirahealth.com . This U.S. made and manufactured product is the first FDA authorized, prescription, molecular diagnostic test for

RHEA-AI

neutral

02/09/21 4:05 PM

Nasdaq : LHDX

Lucira Health Announces Closing of its Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Lucira Health, Inc. ("Lucira Health" or "Lucira"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the closing of its upsized initial public offering of 10,350,000 shares of its common

RHEA-AI

neutral